[HTML][HTML] Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment

MG Mazza, M Palladini, S Poletti, F Benedetti - CNS drugs, 2022 - Springer
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic is still spreading worldwide
over 2 years since its outbreak. The psychopathological implications in COVID-19 survivors …

[HTML][HTML] A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies

CX Li, S Noreen, LX Zhang, M Saeed, PF Wu… - Biomedicine & …, 2022 - Elsevier
Coronavirus is a family of viruses that can cause diseases such as the common cold, severe
acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS). The …

[HTML][HTML] Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform …

G Reis, EA dos Santos Moreira-Silva… - The Lancet Global …, 2022 - thelancet.com
Background Recent evidence indicates a potential therapeutic role of fluvoxamine for
COVID-19. In the TOGETHER trial for acutely symptomatic patients with COVID-19, we …

Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants

T Oskotsky, I Marić, A Tang, B Oskotsky… - JAMA network …, 2021 - jamanetwork.com
Importance Antidepressant use may be associated with reduced levels of several
proinflammatory cytokines suggested to be involved with the development of severe COVID …

Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort

CL Clelland, K Ramiah, L Steinberg, JD Clelland - BJPsych Open, 2022 - cambridge.org
BackgroundDuring the first wave of the coronavirus disease 2019 (COVID-19) pandemic,
patients with confirmed cases in New York State accounted for roughly 25% of total US …

[HTML][HTML] Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19

M Mahdi, L Hermán, JM Réthelyi, BL Bálint - International Journal of …, 2022 - mdpi.com
Mapping non-canonical cellular pathways affected by approved medications can accelerate
drug repurposing efforts, which are crucial in situations with a global impact such as the …

[HTML][HTML] The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis

H Nakhaee, M Zangiabadian, R Bayati, M Rahmanian… - PLoS …, 2022 - journals.plos.org
Introduction Clinical Depression and the subsequent low immunity is a comorbidity that can
act as a risk factor for the severity of COVID-19 cases. Antidepressants such as Selective …

[HTML][HTML] Blocking TNF signaling may save lives in COVID-19 infection

V Ablamunits, C Lepsy - Molecular Biology Reports, 2022 - Springer
Global vaccination effort and better understanding of treatment strategies provided a ray of
hope for improvement in COVID-19 pandemic, however, in many countries, the disease …

Antidepressant psychopharmacology: is inflammation a future target?

F Benedetti, R Zanardi, MG Mazza - International clinical …, 2022 - journals.lww.com
Raised inflammatory setpoints have been associated with major depression and its
detrimental consequences on brain function, as they lead to increased production of …

[HTML][HTML] Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19

E Dąbrowska, B Galińska-Skok, N Waszkiewicz - Life, 2021 - mdpi.com
The dysfunctional effects of the coronavirus disease 2019 (COVID-19) infection on the
nervous system are established. The manifestation of neuropsychiatric symptoms during …